Skip to main content
. 2020 Feb 24;21(4):1537. doi: 10.3390/ijms21041537

Figure 2.

Figure 2

Mechanisms involved in microenvironment-mediated resistance to FLT3 inhibitors. 1. FLT3L/FLT3R-WT 2. FGF2/FGFR1 axis 3. SDF1/CXCR4 axis 4. CYP3A4-mediated degradation of FLT3 inhibitors (FLT3i) 5. GM-CSF or IL3/IL3R axis.